{"transactions":[{"id":1463083,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T22:47:07.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":117455,"source":{"system":"sec-edgar","filing":"0001493152-24-026088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026088/ownership.xml","form_type":"4"}},{"id":1479070,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-15T00:45:54.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":83671,"source":{"system":"sec-edgar","filing":"0001493152-24-023996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023996/ownership.xml","form_type":"4"}},{"id":1672069,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:54.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Knight of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year"}],"balance_after":75375,"source":{"system":"sec-edgar","filing":"0001493152-24-003692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003692/ownership.xml","form_type":"4"}},{"id":1672068,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:54.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Knight of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":62707,"source":{"system":"sec-edgar","filing":"0001493152-24-003692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003692/ownership.xml","form_type":"4"}},{"id":1833941,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Knight of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":50840,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":1833940,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Knight of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Knight continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":40595,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":1833939,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Knight of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":30675,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":2096207,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-tradeable Warrants (right to buy)","published_at":"2022-12-05T21:12:40.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":8163,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."}],"balance_after":8163,"derivative":{"exercise_price":7.656,"exercise_date":"2022-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001493152-22-034466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034466/ownership.xml","form_type":"4"}},{"id":2096206,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-05T21:12:40.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":8163,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."}],"balance_after":8163,"derivative":{"exercise_price":7.35,"exercise_date":"2022-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001493152-22-034466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034466/ownership.xml","form_type":"4"}},{"id":2096205,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2022-12-05T21:12:40.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":8163,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."}],"balance_after":22448,"source":{"system":"sec-edgar","filing":"0001493152-22-034466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034466/ownership.xml","form_type":"4"}}]}